Delivery Order SPE2DB22D1106-SPE2DB24FDVU2
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $74,904.80 for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product. The award was issued by the Defense Logistics Agency (DLA) on March 6, 2024, with a completion date of March 7, 2024. The contract has a Firm Fixed Price pricing type and does not include any set-aside designations, indicating open competition. Amerisourcebergen Drug Corp holds a...
- This federal contract award, valued at $30,720.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccination product, with a completion date of February 29, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing structure, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, a major pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,034.55 firm-fixed-price delivery order is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product. The award has an ultimate completion date of January 9, 2024 and was made without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $4,939.15 firm fixed-price delivery order is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product. The contract has an ultimate completion date of December 8, 2023. This award is not associated with a set-aside designation, indicating it was competed among all eligible vendors. The contract is part of a larger Indefinite...
- This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) is a delivery order valued at $5,842.60 for the supply of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of June 1, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $4,478.40 Firm Fixed Price Delivery Order issued by the Defense Logistics Agency (DLA) Troop Support Medical. The award is for the pharmaceutical product TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, with a completion date of September 15, 2021. This transaction is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,924.64 firm fixed-price delivery order is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a medical commodity. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
- This federal contract award, valued at $31,261.30, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product, with a period of performance through January 26, 2024. This contract award is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, worth $4,939.19, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product, with a completion date of January 29, 2024. This contract is not designated as a set-aside and was awarded under a Firm Fixed Price Delivery Order contract type. Amerisourcebergen Drug Corp is a major pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $18,726.20 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the supply of 4,563,415,015 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine, with a period of performance through January 24, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FDVU2Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML medical supplies. The $18,726.20 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of January 19, 2024. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.7k | 1/18/24 |